Technical Analysis for CKPT - Checkpoint Therapeutics, Inc.

Grade Last Price % Change Price Change
grade F 2.83 -6.60% -0.20
CKPT closed down 6.6 percent on Thursday, July 18, 2019, on 31 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Down
See historical CKPT trend table...

Date Alert Name Type % Chg
1,2,3 Retracement Bearish Bearish Swing Setup 0.00%
180 Bearish Setup Bearish Swing Setup 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Inside Day Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
Wide Bands Range Expansion -6.60%
Oversold Stochastic Weakness -6.60%
Inside Day Range Contraction -0.70%
Wide Bands Range Expansion -0.70%

Older signals for CKPT ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Checkpoint Therapeutics, Inc. is an immuno-oncology biopharmaceutical company. The Company is focused on the acquisition, development and commercialization of non-chemotherapy, immune-enhanced combination treatments for patients with solid tumor cancers. The Company is engaged in developing a portfolio of human immuno-oncology targeted antibodies. The portfolio of antibodies that it licensed includes antibodies targeting programmed death-ligand 1 (PD-L1), glucocorticoid-induced Tumor necrosis factor receptor (TNFR) related protein (GITR) and carbonic anhydrase IX (CAIX). It focuses on developing the immuno-oncology and checkpoint inhibitor antibodies. It is developing three oral, small molecules, targeted anti-cancer agents, consisting of an inhibitor of epidermal growth factor receptor (EGFR) mutations, an inhibitor of the bromodomain and extra-terminal (BET) protein, BRD4, and an inhibitor of poly (ADP-ribose) polymerase (PARP). Its pipeline of products includes CK-101 and CK-103.
Medicine Immunology Antibodies Chemotherapy Immune System Cancer Immunotherapy Epidermal Growth Factor Receptor Immune Checkpoint Solid Tumor Cancers Checkpoint Inhibitor
Is CKPT a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 5.2
52 Week Low 1.5
Average Volume 157,376
200-Day Moving Average 3.1581
50-Day Moving Average 3.936
20-Day Moving Average 3.2385
10-Day Moving Average 2.989
Average True Range 0.3672
ADX 35.98
+DI 9.0545
-DI 21.3171
Chandelier Exit (Long, 3 ATRs ) 3.5384
Chandelier Exit (Short, 3 ATRs ) 3.7516
Upper Bollinger Band 3.9532
Lower Bollinger Band 2.5238
Percent B (%b) 0.21
BandWidth 44.137718
MACD Line -0.3043
MACD Signal Line -0.2903
MACD Histogram -0.014
Fundamentals Value
Market Cap 71.79 Million
Num Shares 25.4 Million
EPS -1.10
Price-to-Earnings (P/E) Ratio -2.57
Price-to-Sales 75.20
Price-to-Book 6.30
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.36
Resistance 3 (R3) 3.39 3.25 3.27
Resistance 2 (R2) 3.25 3.11 3.23 3.24
Resistance 1 (R1) 3.04 3.03 2.97 3.01 3.21
Pivot Point 2.89 2.89 2.86 2.88 2.89
Support 1 (S1) 2.68 2.76 2.61 2.65 2.45
Support 2 (S2) 2.54 2.67 2.52 2.42
Support 3 (S3) 2.33 2.54 2.39
Support 4 (S4) 2.30